Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Glyphic Biotechnologies

Request full access

A biotechnology startup revolutionizing the field of proteomics

Berkeley, United StatesFounded 2021Biotech & Life Sciences

About Glyphic Biotechnologies

Glyphic Biotechnologies is a biotechnology startup revolutionizing the field of proteomics. The company is developing a first-of-its-kind, next-generation protein sequencing platform. This platform allows researchers to gain novel insights into biology and disease, providing a deeper understanding of what proteins reveal about bodily functions. Operating in the biotechnology market, Glyphic Biotechnologies primarily serves researchers and institutions focused on biological and medical research. The business model revolves around offering advanced sequencing services and potentially licensing its technology to other entities. Revenue is generated through service fees and technology licensing agreements.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2021
Headquarters
Berkeley, United States
Employees
33
Open positions
6
Dealroom signal
86.6/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, DNA, Genetics and genomics, Spinout, Biotech and Pharma, proteomics, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

8 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VC✓Equity / VC Nov 2024 $33M $133M LongeVC ↗
GRANTOther financing Sep 2023 $409K — National Institutes of Health ↗
Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Growth signals

Glyphic Biotechnologies website traffic

Latest recorded traffic for Glyphic Biotechnologies is 7.9K monthly website visits, down 1.2% over the last three months. Glyphic Biotechnologies's team grew 17.9% over the past year.

Latest monthly visits7.9K 3-month web change-1.2% 1-year team growth+17.9%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Glyphic Biotechnologies in the Berkeley ecosystem

Live from Dealroom

The Glyphic Biotechnologies office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

21 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed10 investors entered at this stage

  • OMX Ventures
  • Wing Venture Capital
  • Artis Ventures
  • Osage University Partners
  • Trevor Martin
  • Cantos Ventures
  • Civilization Ventures
  • Axial VC
  • National Institutes of Health
  • Johnson & Johnson Innovation

Series A1 investor entered at this stage

  • LongeVC

Other known investors10 additional known investors

  • Falling Walls Foundation
  • Massachusetts Institute of Technology
  • BioTools Innovator
  • Bluebirds Capital
  • California Life Sciences
  • Calm Ventures
  • FoundersX Ventures
  • QB3
  • StartOut Growth Lab
  • StartX
Team profiled 12 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States97.1%
🇬🇧 United Kingdom2.9%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Glyphic Biotechnologies on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Glyphic Biotechnologies’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.